Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of OC000459 Dosed Twice Daily for 28 Days in Asthmatic Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria At Screening:~* Male or female asthmatics, any racial group. Females of childbearing potential must practise two forms of contraception~* Non smokers~* Mild to moderate asthmatics according to GINA guidelines for at least 12 months.~* History of asthma symptoms increasing in response to external allergens.~* Testing positive on skin prick test to an allergen associated with the subject's asthma~Exclusion Criteria:~* Use of inhaled or local corticosteroids in the period from 28 days prior to screening.~* Receipt of prescribed or over the counter medication within 14 days of the first study day.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: f

Study Arms:
- OC000459 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).